Supernus Pharmaceuticals Inc
LSE:0LB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
LSE:0LB2
|
US |
|
F
|
Freeport-McMoRan Inc
XBER:FPMB
|
US |
|
Paramount Global
NASDAQ:PSKY
|
US |
|
D
|
Dongfang Electric Corp Ltd
OTC:DNGFF
|
CN |
|
Nippon Sanso Holdings Corp
OTC:TYNPF
|
JP |
|
Spotify Technology SA
NYSE:SPOT
|
LU |
|
A
|
America Movil SAB de CV
F:MV9A
|
MX |
|
S
|
Snam SpA
SWB:SNM
|
IT |
|
LNA Sante SA
PAR:LNA
|
FR |
|
F
|
Fomento de Construcciones y Contratas SA
DUS:FCC
|
ES |
|
Allstate Corp
NYSE:ALL
|
US |
|
Aviva PLC
F:GU8
|
UK |
Shareholder Yield
Current shareholder yield for 
0LB2 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0LB2 Price
Supernus Pharmaceuticals Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -24% |
| Market Capitalization | 2.8B USD |
| Shares Outstanding | 57 340 000 |
| Percentage of Shares Shorted |
N/A
|
